PURPOSE: To investigate the function of connective tissue growth factor (CTGF), a matricellular protein of the CCN (Cyr61/CTGF/Nov) family, in retinal vasculature during development and ischemia. METHODS: CTGF expression was determined using RT-PCR, immunohistochemistry, and transgenic mice carrying CTGF promoter-driven-GFP. CTGF antibody was intraocularly injected into neonates at postnatal day (P)2, and its effect on retinal angiogenesis was analyzed at P4. Transgenic animals expressing GFP regulated by the glial fibrillary acidic protein promoter were used for astrocyte visualization. Retinal vascular occlusion was introduced by rose Bengal and laser photocoagulation on chimeric mice that were reconstituted with GFP+ bone marrow cells. Vascular repair in response to VEGF-A and CTGF was analyzed. RESULTS: A temporal increase in CTGF at both mRNA and protein levels was observed in the ganglion cell layer and inner nuclear layer during development. Endothelial cells and pericytes were identified as the main cellular sources of CTGF during retinal angiogenesis. CTGF stimulated the migration of astrocytes, retinal endothelial cells, and pericytes in vitro. Inhibition of CTGF by specific antibody affected vascular filopodial extension, growth of the superficial vascular plexus, and astrocyte remodeling. In adult mice, CTGF was prominently expressed in the perivascular cells of arteries. CTGF activated bone marrow-derived perivascular cells and promoted fibrovascular membrane formation in the laser-induced adult retinopathy model. CONCLUSIONS: CTGF is expressed in vascular beds and acts on multiple cell types. It is important for vessel growth during early retinal development and promotes the fibrovascular reaction in murine retinal ischemia after laser injury.
PURPOSE: To investigate the function of connective tissue growth factor (CTGF), a matricellular protein of the CCN (Cyr61/CTGF/Nov) family, in retinal vasculature during development and ischemia. METHODS:CTGF expression was determined using RT-PCR, immunohistochemistry, and transgenic mice carrying CTGF promoter-driven-GFP. CTGF antibody was intraocularly injected into neonates at postnatal day (P)2, and its effect on retinal angiogenesis was analyzed at P4. Transgenic animals expressing GFP regulated by the glial fibrillary acidic protein promoter were used for astrocyte visualization. Retinal vascular occlusion was introduced by rose Bengal and laser photocoagulation on chimeric mice that were reconstituted with GFP+ bone marrow cells. Vascular repair in response to VEGF-A and CTGF was analyzed. RESULTS: A temporal increase in CTGF at both mRNA and protein levels was observed in the ganglion cell layer and inner nuclear layer during development. Endothelial cells and pericytes were identified as the main cellular sources of CTGF during retinal angiogenesis. CTGF stimulated the migration of astrocytes, retinal endothelial cells, and pericytes in vitro. Inhibition of CTGF by specific antibody affected vascular filopodial extension, growth of the superficial vascular plexus, and astrocyte remodeling. In adult mice, CTGF was prominently expressed in the perivascular cells of arteries. CTGF activated bone marrow-derived perivascular cells and promoted fibrovascular membrane formation in the laser-induced adult retinopathy model. CONCLUSIONS:CTGF is expressed in vascular beds and acts on multiple cell types. It is important for vessel growth during early retinal development and promotes the fibrovascular reaction in murineretinal ischemia after laser injury.
Authors: Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith Journal: Invest Ophthalmol Vis Sci Date: 2010-06 Impact factor: 4.799
Authors: Gerard J Madlambayan; Jason M Butler; Koji Hosaka; Marda Jorgensen; Dongtao Fu; Steven M Guthrie; Anitha K Shenoy; Adam Brank; Kathryn J Russell; Jaclyn Otero; Dietmar W Siemann; Edward W Scott; Christopher R Cogle Journal: Blood Date: 2009-08-28 Impact factor: 22.113
Authors: Esther J Kuiper; Marc D de Smet; Jan C van Meurs; H Stevie Tan; Michael W T Tanck; Noelynn Oliver; Frans A van Nieuwenhoven; Roel Goldschmeding; Reinier O Schlingemann Journal: Arch Ophthalmol Date: 2006-10
Authors: Jason M Butler; Steven M Guthrie; Mehmet Koc; Aqeela Afzal; Sergio Caballero; H Logan Brooks; Robert N Mames; Mark S Segal; Maria B Grant; Edward W Scott Journal: J Clin Invest Date: 2005-01 Impact factor: 14.808
Authors: Debra F Higgins; Mangatt P Biju; Yasuhiro Akai; Anton Wutz; Randall S Johnson; Volker H Haase Journal: Am J Physiol Renal Physiol Date: 2004-08-17
Authors: Sriniwas Sriram; Jennifer A Tran; Xiaoqing Guo; Audrey E K Hutcheon; Andrius Kazlauskas; James D Zieske Journal: Exp Eye Res Date: 2017-06-06 Impact factor: 3.467
Authors: Liya Pi; Anitha K Shenoy; Jianwen Liu; Seungbum Kim; Nikole Nelson; Huiming Xia; William W Hauswirth; Bryon E Petersen; Gregory S Schultz; Edward W Scott Journal: FASEB J Date: 2012-05-18 Impact factor: 5.191
Authors: Sarah X Zhang; Jacey H Ma; Maulasri Bhatta; Steven J Fliesler; Joshua J Wang Journal: Prog Retin Eye Res Date: 2014-12-18 Impact factor: 21.198
Authors: Andrew J Bryant; Ryan P Carrick; Melinda E McConaha; Brittany R Jones; Sheila D Shay; Christy S Moore; Thomas R Blackwell; Santhi Gladson; Niki L Penner; Ankita Burman; Harikrishna Tanjore; Anna R Hemnes; Ayub K Karwandyar; Vasiliy V Polosukhin; Megha A Talati; Hui-Jia Dong; Linda A Gleaves; Erica J Carrier; Christa Gaskill; Edward W Scott; Susan M Majka; Joshua P Fessel; Volker H Haase; James D West; Timothy S Blackwell; William E Lawson Journal: Am J Physiol Lung Cell Mol Physiol Date: 2015-12-04 Impact factor: 5.464
Authors: Daniel J Gibson; Liya Pi; Sriniwas Sriram; Cong Mao; Bryon E Petersen; Edward W Scott; Andrew Leask; Gregory S Schultz Journal: Invest Ophthalmol Vis Sci Date: 2014-04-01 Impact factor: 4.799
Authors: Andrea E Dillinger; Sabrina Kuespert; Franziska Froemel; Ernst R Tamm; Rudolf Fuchshofer Journal: Cell Tissue Res Date: 2021-01-29 Impact factor: 5.249